Vir Biotechnology: Needham raises target price to $24 from $20
VIR•Needham raised its target price for Vir Biotechnology to $24 from $20.
Related News
Constellation Energy Corp: CIBC raises target price to $346 from $343
CEG•
China's crude oil imports recover, fuel exports not so much
USO•
Enerpac Tool Group presents strategy targeting growth 200-300 basis points above market
EPAC•
BillionToOne, Inc.: Piper Sandler cuts target price to $130 from $140
BLLN•
Brookfield Corporation: JPMorgan raises target price to $65 from $56
BN•